Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Cochlear ( (AU:COH) ).
Cochlear Limited has notified the market of the issue of 8,156 unquoted service rights under its employee incentive scheme, effective 31 March 2026. The new rights, which will not be quoted on the ASX, form part of the company’s ongoing approach to staff remuneration and retention, aligning employee rewards with longer-term corporate performance.
The issuance of these service rights marginally increases Cochlear’s pool of unquoted equity-based incentives, reinforcing the company’s use of equity to incentivise key personnel. While not altering the publicly traded share count, such grants can influence future dilution and signal continued investment in human capital to support the company’s growth objectives.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$172.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a medical device company specialising in implantable hearing solutions, including cochlear implants and related hearing technologies. Listed on the ASX under the code COH, it operates in the global hearing health market, serving patients with moderate to profound hearing loss and working closely with clinicians and healthcare providers.
YTD Price Performance: -33.04%
Average Trading Volume: 221,424
Technical Sentiment Signal: Sell
Current Market Cap: A$11.27B
For a thorough assessment of COH stock, go to TipRanks’ Stock Analysis page.